Phosphatidylserine (PS) is a lipid found in the cell membrane. When exposed on the outside of a cell during stress or during cell death, PS can trigger immune suppression. PS also engages PS receptors on immune cells, resulting in clearance of the cell and production of immune suppressive factors. One way tumors evade the host immune system is by engaging PS signaling. Therefore, inhibiting PS signaling suppression is a promising option for treating cancer. A recent review highlights the contributions of the TIM and TAM family of receptors to PS signaling and immune suppression in tumors. and some of the immunotherapy strategies targeting these receptors that are being investigated in preclinical and clinical trials. Due to the complexity of PS-induced immune suppression, there are still many unknowns. such as the detailed mechanisms and signaling pathways that are involved. or the consequences of interrupting these signaling pathways. However, these therapies, especially in combination with other agents, hold exciting therapeutic potential for treating many types of cancer.